Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every ...

The Parkinson’s enzyme therapy is still heading toward the clinic, and the deal could grow by up to $1.17bn in milestone ...

The Austin-based microbiome testing company raised a $33M Series B, and adults now outnumber babies in its testing volume.

Swedish biotech will present the Phase II ADVANCE trial design for vaccine candidate ALZ-101 at Alzheimer’s disease ...

First-in-human ER-100 data support dose escalation, with early visual-field signals in two of three glaucoma patients.

Novartis’ President of Biomedical Research, Fiona Marshall, on what it would take for big pharma to go all in on longevity. When the person who runs research for one of the world’s largest drug ...

Researchers say women in Bolotana are reaching 100 at rates that stand out even among the world’s longest-lived people.

As health data multiplies, Longevitix is building a physician-led AI layer designed to turn complexity into continuous preventive care. Preventive medicine is getting to know its patients better than ...

At LIC 2026, investors, scientists and founders examined what survives the journey from longevity hypothesis to human ...

Designerly's Cooper Adwin looks at why generative AI Is re-engineering skin rejuvenation and phasing out animal collagen.